Ibnsina Pharma (EGX:ISPH)

Ibnsina Pharma Revenue

Ibnsina Pharma had revenue of 20.99B EGP in the quarter ending June 30, 2026, with 16.62% growth. This brings the company's revenue in the last twelve months to 83.04B, up 21.99% year-over-year. In the year 2025, Ibnsina Pharma had annual revenue of 76.60B with 37.17% growth.

• Revenue (ttm): 83.04B
• Revenue Growth: +21.99%
• P/S Ratio: 0.16
• Revenue / Employee: 15.10M
• Employees: 5,500
• Market Cap: 13.21B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	76.60B	20.75B	37.17%
Dec 31, 2024	55.84B	21.89B	64.49%
Dec 31, 2023	33.95B	11.68B	52.48%
Dec 31, 2022	22.26B	531.66M	2.45%
Dec 31, 2021	21.73B	3.05B	16.35%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error